Keyphrases
Inhaled Corticosteroids
100%
Airway
100%
Antimicrobial Resistance
100%
Corticosteroid Withdrawal
100%
Metagenome
100%
Corticosteroid Treatment
91%
Treatment Withdrawal
50%
Sputum
25%
Continuation Treatment
25%
16S rRNA Sequencing
25%
Haemophilus
16%
Veillonella
16%
Interactome
16%
Bacterial Load
16%
Commensal
16%
Sputum Samples
16%
Microbial Interactions
16%
Interactome Analysis
16%
Microbial Interaction Network
16%
Microbes
8%
Between-group
8%
Treatment Duration
8%
Tetracycline
8%
Moderate to Severe
8%
Pneumonia
8%
Quantitative PCR
8%
High Abundance
8%
Mean Group
8%
Lactobacillus
8%
Streptococcus Mitis
8%
Haemophilus Influenzae
8%
Prevotella
8%
Current Smokers
8%
Fusobacterium
8%
Moraxella
8%
Multidrug Resistance
8%
Relative Reduction
8%
Eosinophil Count
8%
Fluoroquinolones
8%
Campylobacter
8%
Stable Patients
8%
Fluticasone Furoate
8%
Clinical Insight
8%
Severe COPD
8%
Metagenomic Next-generation Sequencing (mNGS)
8%
Shotgun Sequencing
8%
Macrolide Resistance
8%
Resistome
8%
Rothia mucilaginosa
8%
Compositionality
8%
Olodaterol
8%
β-lactam Resistance
8%
Differential Analysis
8%
Abundant Taxa
8%
Vilanterol
8%
Gemella Sanguinis
8%
Streptococcus Parasanguinis
8%
Microbial Network
8%
Microbiome Characterization
8%
Parvimonas
8%
Immunology and Microbiology
Sputum
100%
Metagenome
100%
Antimicrobial Resistance
100%
Airway
100%
Organismal Interaction
80%
Streptococcus
60%
Taxon
40%
Haemophilus
40%
Veillonella
40%
Metagenomics
40%
Bacterial Load
40%
Lactobacillus
20%
Streptococcus Mitis
20%
Haemophilus influenzae
20%
Real-Time Polymerase Chain Reaction
20%
Prevotella
20%
Gemella
20%
Fusobacterium
20%
Arm
20%
Eosinophil Count
20%
Multidrug Resistance
20%
Commensal
20%
Campylobacter
20%
Resistome
20%
Rothia mucilaginosa
20%
Vilanterol
20%
Moraxella
20%
Streptococcus parasanguinis
20%
Olodaterol
20%
Parvimonas
20%
Microorganism
20%
Fluticasone Furoate
20%
Microbiome
20%